BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 26189247)

  • 1. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia.
    Ruano Y; Torrents M; Ferrer FJ
    Eur J Gynaecol Oncol; 2015; 36(3):245-51. PubMed ID: 26189247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 12. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
    Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
    Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization.
    Chao A; Lin CT; Hsueh S; Chou HH; Chang TC; Chen MY; Lai CH
    Am J Obstet Gynecol; 2004 Apr; 190(4):1046-51. PubMed ID: 15118639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
    Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
    Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
    Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
    Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.
    Jeong NH; Lee NW; Kim HJ; Kim T; Lee KW
    J Obstet Gynaecol Res; 2009 Aug; 35(4):706-11. PubMed ID: 19751331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
    Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia.
    Aerssens A; Claeys P; Beerens E; Garcia A; Weyers S; Van Renterghem L; Praet M; Temmerman M; Velasquez R; Cuvelier CA
    Cytopathology; 2009 Feb; 20(1):27-35. PubMed ID: 18510550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the HPV DNA test in follow-up of treated cervical intraepithelial neoplasia in Bangladesh.
    Nessa A; Rashid MH; Jahan M; Ferdous NE; Nahar PA; Chowdhury A
    Asian Pac J Cancer Prev; 2014; 15(19):8063-7. PubMed ID: 25338985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.